The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Consulting or Advisory Role - Agios; Bayer; Celgene; Novartis; Pfizer
Research Funding - Agios; Celgene; Novartis
Travel, Accommodations, Expenses - Celgene
Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations.
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
Courtney Denton Dinardo
Honoraria - Agios; Daiichi Sankyo; Novartis
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo; Novartis
 
Irina Kline
Employment - Cedars-Sinai
Stock and Other Ownership Interests - Celgene
 
Nora Tu
No Relationships to Disclose
 
Eyal C. Attar
No Relationships to Disclose
 
Eytan M. Stein
No Relationships to Disclose
 
Stéphane de Botton
Honoraria - Agios; Celgene; Novartis; Pfizer; Pierre Fabre; Sanofi; Servier
Consulting or Advisory Role - Agios; Celgene; Novartis; Pierre Fabre; Sanofi; Servier
Research Funding - Agios
Travel, Accommodations, Expenses - Agios; Celgene; Novartis; Pfizer